---
layout: post
title: "In Silico Study of Soursop Leaf Compounds (Annona muricata L.) As Inhibitors of BRAF V600E Kinase in Melanoma Cancer"
author: "Audry Rahma Dewayani, Salsabil Ghaliya, Natashya Parameswari, Alya Puteri Agustina Pribadi, Husna Muharram Ahadi, Diah Lia Aulifa, Angela Alysia Elaine, Bernap Dwi Putra Sitinjak"
description: "Melanoma is a cancer that develops in melanocytes and manifests itself on the skin as lumps and uneven skin pigmentation A chemotherapeutic medication called Vemurafeni"
categories: jfu
canonical_url: https://jurnal.harianregional.com/jfu/id-88474
comments: true
citation_abstract_html_url: "https://jurnal.harianregional.com/jfu/id-88474"
citation_pdf_url: "https://jurnal.harianregional.com/jfu/full-88474"
tags:

---

## Authors:
Audry Rahma Dewayani, Salsabil Ghaliya, Natashya Parameswari, Alya Puteri Agustina Pribadi, Husna Muharram Ahadi, Diah Lia Aulifa, Angela Alysia Elaine, Bernap Dwi Putra Sitinjak

## Abstract:
"Melanoma is a cancer that develops in melanocytes and manifests itself on the skin as lumps and uneven skin pigmentation. A chemotherapeutic medication called Vemurafenib is one of the medicines used to treat this malignancy. Chemotherapeutic drugs, on the other hand, are known to induce a variety of adverse effects in the body, thus alternative substances with the same potential but fewer side effects must be sought. This study was conducted utilizing an in silico technique, which included molecular docking, as well as Lipinski rules and PreADMET to predict the pharmacokinetic profile. Compounds found in soursop leaves (Annona muricata L.) have been shown to inhibit cell division by interacting with the BRAF V600E receptor. Reticuline has a Gibbs energy of -8.78; a 395.39 nM inhibition constant; and binds to the amino acids GLN A:530, CYS A: 532, and ASP A: 594."

### Keywords
*Keyword Not Available*

### Downloads:
Download data is not yet available.

{% include adsense.html %}
## References
- Ali, Z., Yousaf, N., & Larkin, J. (2013). Melanoma epidemiology, biology and prognosis. EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer.  11(2), 81–91. https://doi.org/10.1016/j.ejcsup.2013.07.012
- American Cancer Society. (2019). Chemotherapy for Melanoma Skin Cancer. https://www.cancer.org/cancer/melanoma-skin-cancer/treating/chemotherapy.html#references
- Doak, B.C., Over, B., Giordanetto, F., dan Kihlberg, J. (2014). Oral Druggable Spade Beyond The Rule of 5: Insights from Drugs and Clinical Candidates. Chemistry & Biology, 21 (9), 1115-1142. https://doi.org/10.1016/j.chembiol.2014.08.013
- Goodwin, R.J.A., Bunch, J., dan McGinnity, D.F. 2017. Mass Spectrometry Imaging in Oncology Drug Discovery. Advances in Cancer Research, 134, 133-171. https://doi.org/10.1016/bs.acr.2016.11.005
- Khaddour, K., Kurn, H., dan Zito, P.M. (2022). Vemurafenib. https://www.ncbi.nlm.nih.gov/books/NBK535429/
- Kilo, A.L., Aman, L. O., Sabihi, I., dan Kilo, J.L. (2019). Studi Potensi Pirazolin Tersubstitusi 1-N dari Tiosemikarbazon sebagai Agen Antimuba Melalui Uji in silico. Indo. J. Chem. Res., 7 (1), 9-16. https://ojs3.unpatti.ac.id/index.php/ijcr/article/view/725
- Kumar, R., Giri, A., Nadendla, R. R. (2018). In Silico ADME Profiling Of CDK9 Inhibitors. Journal of Scientific Research in Pharmacy. 7(3): 30-34. https://doi.org/10.5281/zenodo.1207094
- Lestari,  T.  2015.  Studi  Interaksi  Senyawa  Turunan  1,3- Dibenzoiltiourea   sebagai   Ribonukleotida   Reduktase Inhibitor. Jurnal Farmasi Indonesia. Vol. 7: 163–169
- Ma, C. & Armstrong, A. W. (2013). Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2. Journal of Dermatological Treatment, 25(5), 401–408. https://doi.org/10.3109/09546634.2013.813897
- Mustika, D.N.,dan Fakih, T.M., Aprilia, H. 2021. Uji In-Silico Aktivitas Melanogenesis Senyawa Turunan Betacyanin Buah Naga Merah (Hylocereus Polyhizuz) sebagai Inhibitor Enzim Tirosinase. Prosiding Farmasi, 7(2): 443-446. https://karyailmiah.unisba.ac.id/index.php/farmasi/article/view/29391/
- National Cancer Institute. (2021). Melanoma Treatment. https://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq
- Nurgali, K., Jagoe, R. T., & Abalo, R. (2018). Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?. Frontiers in pharmacology, 9, 245. https://doi.org/10.3389/fphar.2018.00245
- Ott PA.(2019). Intralesional Cancer Immunotherapies. Hematol Oncol Clin North Am, 33(2), 249-260. https://doi.org/10.1016/j.hoc.2018.12.009
- Pratama, A.A., Rifai, Y., Marzuki,A. (2017). Docking Molekuler Senyawa 5,5’-Dibromometilsesamin. Majalah Farmasi dan Farmakologi, 21(3), 67-69. https://doi.org/10.20956/mff.v21i3.6857
- Prieto-Callejero, B., Rivera, F., Fagundo-Rivera, J., Romero, A., Romero-Martín, M., Gómez-Salgado, J., & Ruiz-Frutos, C. (2020). Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer. Medicine, 99(33), 21695. https://doi.org/10.1097/MD.0000000000021695
- Saginala, K.,Barsouk, A., Aluru, J.S., Rawla, P., Barsouk,A. (2021). Epidemiology of Melanoma. Medical Science, 9(4), 63. https://doi.org/10.3390%2Fmedsci9040063
- Santarpia, L., Lippman, S.L., dan El-Naggar, A. 2012. Targeting the Mitogen-Activated Protein Kinase RAS-RAF Signaling Pathway in Cancer Therapy. Expert Opinion in Theurapeutic Targets, 16(1), 113-119. https://doi.org/10.1517/14728222.2011.645805
- Siswarni, M., Nurhayani., Sinaga, S. 2016. Ekstraksi asetogenin dari daun dan biji Sirsak (Annona muricata L.) dengan Pelarut Aseton. Jurnal Teknik Kimia USU, 5(2), 1-4. https://doi.org/10.32734/jtk.v5i2.1533
- Syakir, M. A. dan Anggraini, D. I. (2020). Terapi Imunologi Pada Melanoma. Jurnal Ilmiah Kedokteran Indonesia, 8(2), 103–110. https://doi.org/10.53366/jimki.v8i2.118
- Syahputra, B., Ambarsari, L., dan Sumaryada, T. (2014). Simulasi Docking Kurkumin Enol, Bisdemetoksikurkumin dan Analognya sebagai Inhibitor Enzim 12-Lipooksigenase. Jurnal Biofisika, 10(1): 55-67. https://journal.ipb.ac.id/index.php/biofisika/article/view/9354/7334
- Tarhini A, Atzinger C, Gupte-Singh K, Johnson C, Macahilig C, Rao S. (2019). Treatment patterns and outcomes for patients with unresectable stage III and metastatic melanoma in the USA. J Comp Eff Res, 8(7), 461-473. https://doi.org/10.2217/cer-2019-0003
- WHO. (2022). Cancer pada Mei 2022. https://www.who.int/news-room/fact-sheets/detail/cancer
- Wahab, S.M.A., Jantan, I., Haque, Md.A., dan Arshad, L. 2018. Exploring the Leaves of Annona muricata L. as a Source of Potential Anti-inflammatory and Anticancer Agents. Frontiers in Pharmacology, 9(661), 1-20. https://doi.org/10.3389%2Ffphar.2018.00661

### PDF:

{% include adsense1.html %}

<https://jurnal.harianregional.com/jfu/full-88474>

{% include adsense2.html %}

### Published
2023-01-31

### How To Cite
DEWAYANI, Audry Rahma et al.  In Silico Study of Soursop Leaf Compounds (Annona muricata L.) As Inhibitors of BRAF V600E Kinase in Melanoma Cancer.Jurnal Farmasi Udayana, [S.l.], p. 80-88, jan. 2023. ISSN 2622-4607. Available at: <https://jurnal.harianregional.com/jfu/id-88474>. Date accessed: {{ site.time | date: "%d %b. %Y" }}. doi:https://doi.org/10.24843/JFU.2022.v11.i02.p07.

## Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

### Issue
Vol. 11, No. 2, Tahun 2022

### Section 
**Articles**

### Copyright 
{% include inarticle.html %}
<a href="http://creativecommons.org/licenses/by/4.0/" rel="license"><img src="https://i.creativecommons.org/l/by/4.0/88x31.png" alt="Creative Commons License" /></a>
This work is licensed under a <a href="http://creativecommons.org/licenses/by/4.0/" rel="nofollow">Creative Commons Attribution 4.0 International License</a>

{% include multiplex.html %}
